Dr Reddy’s Follows Viatris With Second US Nexavar Rival
Latest In A String Of Significant US Generic Launches For Indian Firm
Hot on the heels of the first US generic Nexavar launch by Viatris, Dr Reddy’s has followed with a second sorafenib rival. The product represents the latest in a string of significant US launches for the Indian company.
